Back
CGRNA
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
🇦🇺 ASX
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
N/A
Annual Growth
5 years average annual capital growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
📈 Performance
Price History
N/A
1M
All Time
Graph
Table
Performance graph isn't available yet for this share
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in CGRNA
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in CGRNA
N/A
CGRNA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in CGRNA also invest in...
Want more shares? Try these...
CGS
Cogstate Ltd. is a global cognitive science company, which engages in delivering software services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-02-13. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
🙌 Performance (5Yr p.a)
46.58%
📊 Share price
$2.43 AUD
📈 HIGH PRICE GROWTH
🩺 HEALTH CARE
CGN Resources Ltd. engages in the exploration and discovery of diamonds. The company is headquartered in Perth, Western Australia. The company went IPO on 2023-10-18. The Company’s flagship Webb Project encompasses a significant 961 square kilometer package of tenements located in the highly prospective West Arunta Orogen in Western Australia. The Webb Project is located in northern Western Australia, in the Aileron province of the West Arunta Orogen (WAO). The Company’s six targets include Tantor, Surus, Shep, Hathi, Snorky and Horton. The company considers four potential deposits, including iron oxide copper gold (IOCG)-style, Orthomagmatic nickel, rare earth elements (REE) mineralization and Diamondiferous kimberlites.
📊 Share price
$0.09 AUD
⛏️ MINING